Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. (ACXP) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ACXP · as of Jun 9, 2026
Activity summary
Buy transactions
12
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Acurx Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ACXP insider buying and selling by quarter
ACXP insider selling · ACXP insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
ACXP executive sell shares · ACXP board member insider trading · ACXP insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 6, 2025 | Scodari Joseph C Director | Purchase | 24,631 | $25K | Form 4 |
| Jan 6, 2025 | Sailer Carl Director | Purchase | 24,631 | $25K | Form 4 |
| Jan 6, 2025 | LUCI DAVID P President and CEO · Director | Purchase | 49,261 | $50K | Form 4 |
| Jan 6, 2025 | Donohue James J. Director | Purchase | 9,852 | $10K | Form 4 |
| Jan 6, 2025 | DELUCCIA ROBERT J Director | Purchase | 49,261 | $50K | Form 4 |
| Jan 6, 2025 | DEAN JACK H Director | Purchase | 9,852 | $10K | Form 4 |
| Jan 19, 2024 | Sailer Carl Director | Option | 19,737 | $70K | Form 4 |
| Dec 2, 2021 | DELUCCIA ROBERT J Director | Gift | 40,000 | — | Form 4 |
| Dec 12, 2023 | DELUCCIA ROBERT J Director | Gift | 40,000 | — | Form 4 |
| Jan 3, 2024 | DELUCCIA ROBERT J Director | Option | 19,737 | $70K | Form 4 |
| Dec 22, 2023 | DELUCCIA ROBERT J Director | Gift | 30,000 | — | Form 4 |
| Jan 3, 2024 | LUCI DAVID P President and CEO · Director | Option | 19,737 | $70K | Form 4 |
| Jul 27, 2022 | DELUCCIA ROBERT J Director | Purchase | 19,737 | $75K | Form 4 |
| Nov 23, 2021 | Sailer Carl Director | Purchase | 5,161 | $25K | Form 4 |
| Nov 19, 2021 | DELUCCIA ROBERT J Director | Purchase | 5,034 | $25K | Form 4 |
| Nov 19, 2021 | LUCI DAVID P President and CEO · Director | Purchase | 5,200 | $25K | Form 4 |
| Jun 29, 2021 | Sailer Carl Director | Purchase | 12,500 | $75K | Form 4 |
LUCI DAVID P
President and CEO · Director
Date
Jan 6
Shares
49,261
Price
$1.01
Value
$50K
LUCI DAVID P
President and CEO · Director
Date
Jan 3
Shares
19,737
Price
$3.55
Value
$70K
LUCI DAVID P
President and CEO · Director
Date
Nov 19
Shares
5,200
Price
$4.80
Value
$25K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ACXP insider trading
ACXP insider trades
Acurx Pharmaceuticals, Inc. (ACXP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ACXP. Over the past 12 months, 0 insiders have filed transactions with the SEC. ACXP insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Acurx Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ACXP insider trading · 5 questionsThe insiders of Acurx Pharmaceuticals, Inc. (ACXP) include executives and directors such as ACXP, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026